Fulcine

Quick links to important sections

Fulcine

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fulcine

Property Description
Active ingredient Griseofulvin (C17H17ClO6)
Form Oral Tablet, Oral Suspension
Pharmacological class Systemic Antifungal Agent
Common use Persistent Fungal Infections (Dermatophytoses)
Origin Natural (Metabolite of Penicillium griseofulvum)

Fulcine and Griseofulvin: Defining a Systemic Antifungal Agent

Fulcine is a medicine containing the active ingredient Griseofulvin, which is a Systemic Antifungal Agent and is a prescription-only (Rx) product. Its fundamental purpose is addressing persistent fungal infections, particularly those caused by dermatophytes, which are commonly known as ringworm infections affecting the skin, hair, and nails. The necessity for this medicine is clinically recognized, especially when fungal colonies are entrenched in tissues that cannot be effectively reached by simple external treatments. This systemic approach establishes an internal defense against these specific types of pathogens.

Composition, Forms, and Differentiation

Griseofulvin is derived from a natural source—it is a metabolite produced by the Penicillium griseofulvum fungus, classifying it as an antifungal antibiotic. Fulcine is available for the oral route of administration as an oral tablet or oral suspension. A key differentiating feature across Griseofulvin products is the crystal size: formulations utilize both microsize and ultramicrosize crystalline forms. The ultramicrosize preparation is engineered for enhanced absorption within the gastrointestinal tract, ensuring optimal drug delivery to the systemic circulation compared to the original microsize version. This improved bioavailability factor often influences the overall effectiveness of the medicine.

The Basic Principle of Fungistatic Protection

Griseofulvin functions as a fungistatic agent, meaning its primary action is to inhibit the growth and reproduction of susceptible fungal species, including Microsporum, Epidermophyton, and Trichophyton. The protective benefit arises because, once absorbed systemically, the agent deposits itself in the keratin precursor cells. This unique property allows newly formed hair, nails, and skin to become resistant to further fungal invasion, ensuring that the existing infection is naturally cleared as the healthy, protected tissue grows outward.

Regulatory References

  1. Griseofulvin MedlinePlus Drug Information
  2. Griseofulvin Ultramicrosize FDA Label

What side effects are possible with Fulcine?

Possible Side Effects and Safety Information

The official safety information for Fulcine (Griseofulvin) classifies potential effects across several physiological systems and defines specific constraints for use. Adverse reactions are organized according to frequency and body system in regulatory documents, helping to establish the overall safety profile.

Frequency and System-Organ Class Effects

Classification Examples of Reactions (SOC)
Common Headache (Nervous System); Nausea, Diarrhea (Gastrointestinal Disorders)
Rare Leukopenia, Anemia (Blood Disorders); Severe Skin Reactions (Dermatological); Hepatotoxicity (Liver Disorders)

Commonly reported reactions, such as headache, are sometimes noted in regulatory labels to disappear during continued therapy. Other effects, such as paresthesia (tingling) of the extremities, have been reported after extended periods of use.

Serious Adverse Reactions and Safety Constraints

The medicine is officially associated with rare but potentially serious adverse reactions. These include Severe Cutaneous Reactions (such as Stevens-Johnson syndrome and Toxic Epidermal Necrolysis) and clinically significant Hepatotoxicity (severe liver injury), which are sometimes linked to high dosages or long periods of therapy.

Official labeling lists specific safety constraints. Fulcine is contraindicated in individuals with a history of hypersensitivity to Griseofulvin, and in patients with pre-existing conditions such as Porphyria and Systemic Lupus Erythematosus (SLE). Due to regulatory concerns, the medicine is also contraindicated for use during pregnancy and in patients with severe hepatic impairment. Prolonged therapy requires periodic laboratory monitoring of renal, hepatic, and hematopoietic systems, as stated in official labeling.

Overdose and Emergency Response

Regulatory information indicates that acute overdose experience with Griseofulvin (Fulcine) is limited and is unlikely to require a specific treatment, as no specific antidote is known. Management is strictly symptomatic and supportive.

Officially documented manifestations of overexposure may include gastrointestinal disturbances like nausea, vomiting, and diarrhea, along with neurological effects such as headache, dizziness, confusion, and paresthesia (numbness or tingling).

Mandatory Emergency Actions

The most critical regulatory guidance is to seek immediate medical attention by contacting a Poison Control Center or emergency services immediately if overdose is suspected. Urgent medical evaluation is explicitly required if high exposure is suspected to have triggered severe, life-threatening complications. These documented severe outcomes include signs of hepatotoxicity (liver damage), such as jaundice, or the onset of severe skin reactions (e.g., blistering, peeling, or a burning rash).

Special Considerations

Regulatory labels highlight that the effects of alcohol may be potentiated by this medication, potentially resulting in adverse cardiovascular effects like tachycardia (fast heart rate) and flushing. High-dose exposure or long-term therapy mandates close observation, with periodic monitoring of organ system function, including renal, hepatic, and hematopoietic parameters.

Therapeutic Uses of Fulcine

What Fulcine Treats: Main Uses and Benefits

Fulcine (Griseofulvin) is a systemic agent relevant for fungal infections that may be part of symptomatic management in conditions where complete symptom resolution is sought. Its primary role is applied in addressing dermatophytoses, the ringworm-type infections caused by Trichophyton, Microsporum, and Epidermophyton species. The medicine is commonly used to help with Tinea infections of the hair, nails, and skin.

This medication is generally relevant for persistent or extensive fungal disease, particularly when prior topical antifungal therapy has failed. Common clinical scenarios of use involve the treatment of Tinea capitis (scalp ringworm), Onychomycosis (nail fungus), Tinea corporis (body ringworm), and Tinea cruris (jock itch), which are relevant in contexts involving heightened systemic burden.

The medication is used for managing the associated symptom cluster, including the scaling, severe pruritus (itching), inflammation, and physical degradation of keratin structures. The main therapeutic benefit is commonly used to help with supporting the goal of mycological clearance, which supports the patient by allowing for the growth of healthy tissue that supports general well-being during symptomatic phases. This action contributes to easing the overall symptom load and helps maintain a sense of stability.

“This systemic approach assists with maintaining functional stability when symptoms become more noticeable and disruptive.”


Quick Fact: Relief for Persistent Fungal Symptoms Fulcine is applied when symptoms related to deeply entrenched Tinea infections create noticeable physiological strain and interfere with daily comfort.

Regulatory References

  1. NIH DailyMed Drug Label

Eligibility and Restrictions for Use

Eligibility for Fulcine (Griseofulvin)

Official regulatory documents define strict criteria for using Fulcine, primarily focusing on pre-existing medical conditions, organ function, and reproductive status.

Absolute Contraindications

Griseofulvin is contraindicated and must not be used by patients with:

  • A known history of Porphyria.
  • Hepatocellular Failure or Severe Hepatic Impairment.
  • Systemic Lupus Erythematosus (SLE).
  • Known Hypersensitivity to the drug.

Age-Specific Eligibility

  • Adults are eligible under standard conditions.
  • Pediatric use is not established for children 2 years of age and younger (ultramicrosize formulation).
  • Use is typically established in children over 2 years of age.

Organ Function and Reproductive Restrictions

  • Renal Impairment does not require a dosage adjustment, but Severe Hepatic Impairment is a contraindication.
  • The medicine is contraindicated during Pregnancy (FDA Category X). Women of childbearing potential must use non-hormonal contraception for 4 weeks after therapy.
  • Sexually active males must use effective contraception for 6 months after treatment. Use is not recommended in breastfeeding women.

What should I know about interactions with other medicines?

Fulcine Interactions with other medicines and products

This section outlines the officially documented interaction information for Fulcine (Griseofulvin) as described in government regulatory documents.

Documented Interactions with Medicines

Griseofulvin is officially documented to promote the increased breakdown of certain co-administered medicines through hepatic enzyme induction, leading to their reduced plasma concentrations and diminished therapeutic effect.

Substance Category Documented Interaction Effect
Warfarin-type Anticoagulants Decreased anticoagulant activity, often requiring dosage adjustment.
Oral Contraceptives Reduced efficacy due to enhanced metabolism of the estrogen component, requiring supplemental barrier methods.
Barbiturates (e.g., Phenobarbital) Can depress Griseofulvin activity by decreasing its plasma levels.
Immunosuppressants (e.g., Cyclosporine) Plasma concentrations may be reduced, potentially decreasing their effect.

Official Restrictions and Constraints

  • Alcohol (Ethanol): Consumption of alcoholic beverages is strictly prohibited during therapy due to the documented risk of a severe Disulfiram-like adverse reaction.
  • Food: Regulatory information notes that taking Griseofulvin with a high-fat meal may enhance its systemic absorption.
  • Timing: To prevent interference with absorption, regulatory sources suggest separating the administration of Griseofulvin from certain antacids by at least two hours.
  • Contraception: Women of childbearing potential must use additional barrier contraception during therapy and for four weeks after cessation. Men must use effective barrier contraception during therapy and for six months post-cessation.

Mechanism of Action

Fulcine is selectively incorporated into the bone matrix where it non-covalently binds to the gamma-carboxyglutamic acid residues of the protein osteocalcin. This binding alters the conformational state of the osteocalcin-osteoclast precursor cell interface, thereby modulating RANKL/OPG signaling and resulting in a decrease in osteoclastogenesis. The compound subsequently acts intracellularly as a phosphonate analog, competitively inhibiting the enzyme farnesyl pyrophosphate synthase ( FPPS) within active osteoclasts. Inhibition of FPPS disrupts the necessary prenylation and membrane localization of key small GTPase signaling proteins (e.g., Rho, Rac). This disruption impairs the integrity of the osteoclast cytoskeleton and reduces the formation of the ruffled border, a structure essential for bone resorption. This cellular-level cascade leads to the net modulation of bone turnover physiology.

Dosage and Administration Information

How Fulcine is Used

Fulcine is a medicine containing Griseofulvin, a systemic antifungal agent administered exclusively via the oral route as a tablet or liquid suspension. The method of use is strictly structured around maximizing absorption and treating the infection over a time period sufficient for the replacement of infected tissues.


Administration and Dosage Principles

Principle of Use General Instruction Summary
Administration Context Is taken with a high-fat meal to substantially enhance the absorption of the medicine into the bloodstream, a key factor for its systemic use.
Formulation Dosing The dosing regimen accounts for the specific formulation: Microsize (e.g., 500 mg daily) and Ultramicrosize (e.g., 375 mg daily) are not bioequivalent, and dose adjustments are necessary when switching forms.
Frequency The medicine is generally taken once daily or in divided daily doses, depending on the total required amount.
Preparation The oral suspension requires thorough shaking before a dose is measured for administration.

Duration of Use and Special Populations

Treatment duration is directly related to the infection site and the rate of new, healthy tissue growth. For superficial fungal infections of the skin or scalp, treatment is typically short-term (several weeks). However, for infections of the toenails or fingernails (Onychomycosis), the course of administration is long-term, often requiring continuous use for four to twelve months or longer to allow complete replacement of the infected nail structure. Pediatric patients require a weight-based dose calculated in milligrams per kilogram of body weight, which varies between the microsize and ultramicrosize preparations.

Recent Clinical Evidence

Fulcine: Recent Clinical Evidence

Evidence Supporting the Use for Tinea Capitis (Scalp Ringworm)

The research into Fulcine's use for fungal infections of the scalp, known as Tinea capitis, is composed of numerous studies. The research includes Randomized Controlled Trials (RCTs) and comprehensive meta-analyses, often focusing on children and adolescents. Studies explored the measurement of both mycological clearance (confirmed by laboratory tests) and clinical cure (assessed by the disappearance of visible signs and symptoms). Studies report how symptoms evolved in the observed populations, and this evidence contributes to the broader evidence landscape for this condition. Follow-up durations were limited in some trials, meaning long-term effects are not fully established regarding the durability of clearance after treatment ends.

Evidence for Tinea Corporis, Tinea Cruris, and Tinea Unguium (Skin and Nail Infections)

Research has also explored the use of Fulcine for treating other persistent fungal infections, including Tinea of the body (Tinea corporis), jock itch (Tinea cruris), and nail fungus (Onychomycosis). The evidence base for these uses differs from the research available for scalp infections. Studies were observed in populations with persistent or extensive infections, examining outcomes related to physical discomfort and the clearing of the fungus.

For nail fungus, studies are often long-term comparative clinical trials. Research indicates that studies monitored responses over defined time intervals that extended for many months to observe complete fungal and clinical clearance. The evidence quality for Onychomycosis is described by some sources as limited.

Areas of Uncertainty and Remaining Research Gaps

Certainty remains low regarding long-term outcomes after treatment is completed, especially concerning the risk of the infection returning over many years. Furthermore, comparative evidence against a placebo is uncertain in some areas, as many recent trials compare Fulcine to newer antifungal agents. The results apply only to the populations studied, meaning data for certain groups, such as those with complex underlying health issues, remain insufficient.

Key Studies & References

  1. Oral treatments for toenail onychomycosis: a systematic review - NCBI - NIH
  2. Label: ULTRAMICROSIZE GRISEOFULVIN tablet (FDA DailyMed)
  3. Griseofulvin - eEML - Electronic Essential Medicines List (WHO)

Frequently Asked Questions (FAQ)

Common questions about Fulcine (FAQ)


Q: Can Fulcine be taken with common over-the-counter pain relievers?

Official information explicitly lists interactions with certain prescription medications like warfarin and barbiturates. However, regulatory documents do not specifically list or warn against common over-the-counter pain relievers. Patients are generally advised to inform their healthcare professional about all medicines they take, including any non-prescription pain relievers.


Q: Can elderly patients safely use Fulcine?

Official drug labels indicate that specific safety information regarding the geriatric (older) population is not fully established from current studies. Adults are eligible for treatment, but clinical guidelines often recommend caution or additional monitoring when this medicine is used in older adults due to the limited study data.


Q: Does Fulcine interact with common supplements like vitamins or herbal remedies?

Regulatory documentation focuses on interactions with prescription medicines and alcohol. Although common vitamins and herbal remedies are not specifically named, it is important for patients to disclose all supplements they are taking to their healthcare provider, as potential interactions with certain agents are documented.


Q: What should I do if the side effects I'm having from Fulcine feel unusual?

Official safety information advises that if symptoms of severe reactions occur, such as blistering or peeling of the skin, or signs of liver problems (like dark urine or yellowing of the eyes/skin), immediate medical attention is necessary. For other side effects that feel unusual, consulting a healthcare professional is recommended.


Q: Does Fulcine carry a risk of allergic reaction, and what are the symptoms?

Yes, Fulcine is strictly contraindicated if a patient has a known history of hypersensitivity (allergic reaction) to the drug. Symptoms of allergic-type reactions can include hives, welts, skin rash, or increased sensitivity to sunlight (photosensitivity). If signs of a serious allergic reaction are observed, emergency medical help should be sought immediately.


Q: What kind of studies have compared Fulcine to a placebo?

Regulatory-cited clinical evidence, including clinical trials, confirms that Fulcine is an effective treatment compared to a placebo for conditions like nail fungus (onychomycosis). These studies measure improvement using both mycologic (lab test) and clinical (visible) criteria.


Q: Are there specific patient groups for whom Fulcine is less effective?

Regulatory-cited research indicates that the response to Fulcine is variable and can depend on the specific species of fungus causing the infection. For example, some studies suggest differences in effectiveness between Microsporum and Trichophyton species.


Q: Why is Fulcine sometimes prescribed when other treatments have failed?

Fulcine is classified as a systemic antifungal agent. It is often prescribed when topical (external) therapy is considered inappropriate or has proven unsuccessful, particularly when the infection is deep-seated in tissues like the hair, skin, or nails and requires internal action.


Q: How long does Fulcine stay in your system after stopping treatment?

The active ingredient, Griseofulvin, has a variable half-life in the bloodstream, generally ranging from 9 to 24 hours. The body eliminates about one-third of a single dose through the urine within 24 hours, and more is excreted via the feces over the next few days.


Q: Is Fulcine a medication that needs to be tapered off, or can I stop abruptly?

Official information emphasizes the importance of completing the full prescribed course of treatment, even if the patient feels better, to ensure the infection is fully cleared and to prevent recurrence. However, any decision to start or stop therapy should be made in consultation with a prescribing clinician.


Q: Does Fulcine have a known impact on appetite or weight?

Loss of appetite and nausea are potential side effects listed in official safety information for Fulcine. However, regulatory documents do not specifically list or warn about changes in body weight.


Q: What is the difference in mechanism of action between Fulcine and similar drugs?

Fulcine's active ingredient, Griseofulvin, is unique in its action: it works by binding to structures called tubulin in the fungus, interfering with its microtubule function and preventing the fungus from dividing (mitosis). This mechanism of action differentiates it from many newer antifungal medications.


Q: Can Fulcine make skin more sensitive to the sun?

Yes, official safety information states that Fulcine can cause photosensitivity, which is an increased sensitivity of the skin to sunlight. Regulatory labeling advises on the importance of limiting sun exposure and using protective measures, such as sun block and clothing, during therapy.


Q: Is it possible for Fulcine to cause mood swings or irritability?

Regulatory safety information lists potential effects on the central nervous system (CNS) such as mental confusion and dizziness. While mood swings or irritability are not explicitly listed as common or rare side effects, any observed changes in mood or cognitive function are typically noted as something to discuss with a healthcare provider.


Q: Are there any known allergens in the inactive ingredients of Fulcine?

The inactive ingredients in the oral suspension formulation can include certain compounds like alcohol and parabens (preservatives). It is important for patients to discuss any known allergies to foods, dyes, or preservatives with their healthcare provider prior to starting treatment.


Q: Is there a best time of day to take Fulcine for maximum effect?

Official instructions emphasize that the medicine must be taken with a high-fat meal to substantially improve its absorption into the bloodstream. It is generally taken once daily or in divided daily doses, with the key being to maintain evenly spaced intervals.


Q: What happens if I accidentally take two doses of Fulcine close together?

Official information advises that if you suspect you have taken more than the prescribed amount, or have taken doses too close together, it is advised to seek immediate medical attention or contact a poison control center for guidance.


Q: Are there any common supplements that should absolutely not be taken with Fulcine?

While the label cautions against taking Fulcine with certain photosensitizing agents, it does not specifically name common vitamin or herbal supplements that are absolutely contraindicated. It is essential for patients to inform their prescriber of all supplements and other medicines currently being taken.


Q: What are the initial signs that Fulcine is working for the intended condition?

Fulcine acts by depositing itself in forming keratin, making new tissue resistant to the fungus. The first sign of effectiveness will be visible as the new, healthy, non-infected tissue grows out and replaces the older, infected tissue. The time this takes varies depending on the infection site.


Q: Can Fulcine be split or crushed if I have trouble swallowing pills?

For the ultramicrosize tablet formulation, a bioequivalence study cited in the FDA label found that crushed tablets administered with applesauce were bioequivalent to uncrushed tablets. If the oral suspension is used, it must be shaken thoroughly before measuring the dose.


Q: Why is the dosage of Fulcine often adjusted after the first few weeks?

Official information indicates that dosage may need adjustment based on the patient's weight (especially for children) and their clinical response to treatment. Monitoring the improvement in the infection over time is a key factor in determining the appropriate dosage.


Q: Is it common to feel fatigued after starting Fulcine?

Official safety information lists potential side effects that include dizziness and drowsiness. While general, isolated fatigue is not listed as a common effect, any unusual tiredness or weakness may warrant discussion with a healthcare provider.


Q: What are people referring to when they mention a 'brain fog' side effect from Fulcine?

Official safety information lists potential central nervous system (CNS) effects that patients may interpret as 'brain fog.' These include dizziness, confusion, and impaired co-ordination. Any noticeable changes in cognitive function are important to discuss with a healthcare professional.


Q: Is it true that Fulcine can cause changes in sleep patterns?

Official safety information lists insomnia (sleeplessness) as a possible side effect of Fulcine, though the frequency is typically unknown or less common. Significant changes in sleep patterns are advised to be consulted with a healthcare provider.


Q: If I miss a dose of Fulcine, what is the best thing to do?

Guidance generally suggests that if a dose is missed, patients should take it as soon as they remember, unless it is almost time for the next dose. In that scenario, the missed dose is skipped, and the patient resumes the regular schedule, avoiding taking two doses at once.

How should Fulcine be stored and disposed of?

How to Store and Dispose of Fulcine (Griseofulvin)

The official storage requirements for Fulcine, which contains Griseofulvin, are mandated to preserve drug stability and ensure safety.


Official Storage Conditions

Requirement Standard Mandate
Temperature Store at Controlled Room Temperature between 15 C and 30 C (59 F and 86 F).
Environmental Protect from excess heat and moisture; medication must not be frozen.
Container Keep in the original tightly closed, light-resistant container.
Child Safety Must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Fulcine should be discarded using a local drug take-back program. If a program is unavailable, the product must be mixed with an unappealing substance and placed in a sealed container before being thrown into the household trash, as flushing is not recommended. All personal information must be removed from the container label prior to disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Fulcine found in:

A-Z Index: